Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $209.87 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $124.82 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $48.95 | 5 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $21.38 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $14.72 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.82 | 1 | Otsuka America Pharmaceutical, Inc. ($124.82) |
| 2020 | $16.90 | 1 | Sunovion Pharmaceuticals Inc. ($16.90) |
| 2019 | $36.10 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($21.38) |
| 2018 | $32.05 | 4 | Sunovion Pharmaceuticals Inc. ($32.05) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CNS | ||||||
| 09/19/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Neuroscience | ||||||
| 02/26/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $21.38 | General |
| 06/18/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: CNS | ||||||
| 05/10/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: CNS | ||||||
| 04/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: CNS | ||||||
| 04/11/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 42 | $18,111 | $5,664 |
| 2022 | 2 | 53 | 66 | $14,454 | $5,263 |
| 2021 | 2 | 92 | 225 | $38,300 | $21,806 |
| 2020 | 2 | 71 | 227 | $34,470 | $15,731 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 17 | 17 | $8,114 | $2,359 | 29.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 13 | 14 | $5,602 | $1,983 | 35.4% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2023 | 11 | 11 | $4,395 | $1,322 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 52 | $8,320 | $3,222 | 38.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 13 | 14 | $6,134 | $2,041 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 133 | $21,280 | $11,301 | 53.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 92 | $17,020 | $10,505 | 61.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 205 | $32,270 | $14,289 | 44.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 17 | 22 | $2,200 | $1,442 | 65.5% |
About Dr. Nabil Karroum, M.D
Dr. Nabil Karroum, M.D is a Psychiatry healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104985118.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nabil Karroum, M.D has received a total of $209.87 in payments from pharmaceutical and medical device companies, with $124.82 received in 2024. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($209.87).
As a Medicare-enrolled provider, Karroum has provided services to 257 Medicare beneficiaries, totaling 560 services with total Medicare billing of $48,464. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Minneapolis, MN
- Active Since 12/06/2006
- Last Updated 02/19/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1104985118
Products in Payments
- REXULTI (Drug) $124.82
- LATUDA (Drug) $48.95
- INVEGA SUSTENNA (Drug) $14.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Minneapolis
Dr. Sophia Vinogradov, Md, MD
Psychiatry — Payments: $33,782
Dr. John Simon, M.d, M.D
Psychiatry — Payments: $33,198
Ziad Nahas, Md, MD
Psychiatry — Payments: $21,831
Dr. Alik Widge, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $13,727
Dr. Brian Johns, Md, Mfa, MD, MFA
Psychiatry — Payments: $6,599
Dr. Gihyun Yoon, M.d, M.D
Psychiatry — Payments: $3,607